iNtRON Biotechnology, Inc. (KOSDAQ:048530)

iNtRON Biotechnology Revenue

iNtRON Biotechnology had revenue of 1.23B KRW in the quarter ending June 30, 2025, a decrease of -31.05%. This brings the company's revenue in the last twelve months to 5.14B, down -43.35% year-over-year. In the year 2024, iNtRON Biotechnology had annual revenue of 6.42B, down -33.05%.

• Revenue (ttm): 5.14B
• Revenue Growth: -43.35%
• P/S Ratio: 20.75
• Revenue / Employee: 72.43M
• Employees: 71
• Market Cap: 106.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.42B	-3.17B	-33.05%
Dec 31, 2023	9.59B	-4.42B	-31.57%
Dec 31, 2022	14.01B	-15.30B	-52.21%
Dec 31, 2021	29.31B	-16.13B	-35.49%
Dec 31, 2020	45.43B	37.09B	444.28%